Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKinsey
Medtronic
Moodys
Johnson and Johnson

Last Updated: August 11, 2022

FIRVANQ KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Firvanq Kit, and what generic alternatives are available?

Firvanq Kit is a drug marketed by Azurity and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has nine patent family members in seven countries.

The generic ingredient in FIRVANQ KIT is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Firvanq Kit

A generic version of FIRVANQ KIT was approved as vancomycin hydrochloride by FRESENIUS KABI USA on March 17th, 1987.

  Try it Free

Paragraph IV (Patent) Challenges for FIRVANQ KIT
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FIRVANQ KIT For Oral Solution vancomycin hydrochloride 25 mg/mL and 50 mg/mL 208910 1 2020-05-18

US Patents and Regulatory Information for FIRVANQ KIT

FIRVANQ KIT is protected by nine US patents.

Patents protecting FIRVANQ KIT


Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF C. DIFFICILE-ASSOCIATED DIARRHEA

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF STAPHYLOCOCCAL ENTEROCOLITIS

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF C. DIFFICILE-ASSOCIATED DIARRHEA

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF STAPHYLOCOCCAL ENTEROCOLITIS

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF STAPHYLOCOCCAL ENTEROCOLITIS

Composition and method for vancomycin oral liquid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF C. DIFFICILE-ASSOCIATED DIARRHEA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910-001 Jan 26, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910-001 Jan 26, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910-002 Jan 26, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for FIRVANQ KIT

See the table below for patents covering FIRVANQ KIT around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 4000628 COMPOSITION DE VANCOMYCINE ORALE LIQUIDE ET PROCÉDÉ ASSOCIÉ (COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID) See Plans and Pricing
Japan 6552528 See Plans and Pricing
Canada 2941867 COMPOSITION DE VANCOMYCINE ORALE LIQUIDE ET PROCEDE ASSOCIE (COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Baxter
Express Scripts
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.